News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OSI Pharmaceuticals, Inc. (OSIP) Announces the Results of its Offer to Purchase its 2% Convertible Notes and a Change in the Expiration Time of its Offer to Purchase its 3% Convertible Notes



7/14/2010 8:17:45 AM

MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (the “Company”) announced today that all of its 2% Convertible Senior Subordinated Notes due 2025 (the “2% Notes”) have been surrendered for conversion, as provided for in the Indenture governing the notes. As a result, no 2% Notes remain outstanding and the Company has terminated the Offer to Purchase the 2% Notes that the Company was required to make pursuant to Section 3.9 of the Indenture.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES